Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.40 |
| ▸ | CA2 | P00918 | 3/20 | 0.40 |
| ▸ | CA9 | Q16790 | 2/20 | 0.40 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.37 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.37 |
| ▸ | CXCR2 | P25025 | 2/20 | 0.36 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.35 |
| ▸ | CXCR1 | P25024 | 1/20 | 0.35 |
| ▸ | RXRA | P19793 | 1/20 | 0.34 |
| ▸ | RXRB | P28702 | 1/20 | 0.34 |
| ▸ | RXRG | P48443 | 1/20 | 0.34 |
| ▸ | HTR1D | P28221 | 4/20 | 0.34 |
| ▸ | HTR1A | P08908 | 3/20 | 0.34 |
| ▸ | HTR1B | P28222 | 3/20 | 0.34 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | HTR7 | P34969 | 1/20 | 0.33 |
| ▸ | HTR6 | P50406 | 1/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.33 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.33 |
| ▸ | DRD2 | P14416 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL309328 | 0.89 | ALDH1A1 (0.38) | CA1CA2CA9CXCR2HSD11B1 | |
| SCHEMBL7598776 | 0.83 | CA1 (0.42) | CA1CA2CA9CXCR2HSD11B1 | |
| SCHEMBL2349455 | 0.82 | ACHE (0.44) | CA1CA2CA9HSD11B1RXRA | |
| SCHEMBL926505 | 0.80 | CA2 (0.41) | CA1CA2CA9CXCR2HSD11B1 | |
| SCHEMBL2832043 | 0.80 | CA1 (0.63) | CA1CA2CA9CXCR2HSD11B1 | |
| SCHEMBL2464966 | 0.79 | ALDH1A1 (0.49) | CA1CA2CA9GABRA1GABRB2 | |
| SCHEMBL12620501 | 0.79 | CA9 (0.45) | CA1CA2CA9HSD11B1RXRA | |
| Hydrogen Sulfide SCHEMBL16581552 | 0.78 | CA1 (0.61) | CA1CA2CA9CXCR2HSD11B1 | |
| SCHEMBL2618587 | 0.78 | CA1 (0.33) | CA1CA2CA9GABRA1GABRB2 | |
| SCHEMBL1473223 | 0.77 | HTR1D (0.35) | CA1CA2CA9CXCR2HSD11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11500247-B2 | Liquid crystal sensor | PLATYPUS TECHNOLOGIES, LLC (US) | 2022-11-15 | — | — | US | disclosed |
| US-20200409221-A1 | LIQUID CRYSTAL SENSOR | PLATYPUS TECHNOLOGIES, LLC | 2020-12-31 | — | — | US | disclosed |
| US-20170212088-A1 | DETECTION OF GAS-PHASE ANALYTES USING LIQUID CRYSTALS | PLATYPUS TECHNOLOGIES, LLC | 2017-07-27 | — | — | US | disclosed |
| US-9575037-B2 | Detection of gas-phase analytes using liquid crystals | PLATYPUS TECHNOLOGIES, LLC (US) | 2017-02-21 | — | — | US | disclosed |
| US-20160274084-A1 | DETECTION OF VAPOR PHASE COMPOUNDS BY CHANGES IN PHYSICAL PROPERTIES OF A LIQUID CRYSTAL | PLATYPUS TECHNOLOGIES, LLC | 2016-09-22 | — | — | US | disclosed |
| US-9341576-B2 | Detection of vapor phase compounds by changes in physical properties of a liquid crystal | PLATYPUS TECHNOLOGIES, LLC (US) | 2016-05-17 | — | — | US | disclosed |
| US-20160018371-A1 | DETECTION OF GAS-PHASE ANALYTES USING LIQUID CRYSTALS | PLATYPUS TECHNOLOGIES, LLC | 2016-01-21 | — | — | US | disclosed |
| WO-2014165196-A1 | DETECTION OF GAS-PHASE ANALYTES USING LIQUID CRYSTALS | PLATYPUS TECHNOLOGIES, LLC (US) | 2014-10-09 | — | — | WO | disclosed |
| CN-101646648-B | Tert-butylphenyl sulfonate compound, nonaqueous electrolyte solution for lithium secondary battery using same, and lithium secondary battery using same | UBE IND JP | 2014-07-16 | — | — | CN | disclosed |
| US-20140011097-A1 | TERT-BUTYLPHENYL SULFONATE COMPOUND, NONAQUEOUS ELECTROLYTE SOLUTION FOR LITHIUM SECONDARY BATTERY USING THE SAME, AND LITHIUM SECONDARY BATTERY USING THE SAME | UBE INDUSTRIES, LTD. (JP) | 2014-01-09 | — | — | US | disclosed |
| EP-2344879-A2 | DETECTION OF VAPOR PHASE COMPOUNDS BY CHANGES IN PHYSICAL PROPERTIES OF A LIQUID CRYSTAL | Platypus Technologies, LLC (US) | 2011-07-20 | — | — | EP | disclosed |
| CN-101795998-A | Method for producing aromatic compound | UBE INDUSTRIES | 2010-08-04 | — | — | CN | disclosed |
| US-20100093096-A1 | DETECTION OF VAPOR PHASE COMPOUNDS BY CHANGES IN PHYSICAL PROPERTIES OF A LIQUID CRYSTAL | PLATYPUS TECHNOLOGIES, LLC (US) | 2010-04-15 | — | — | US | disclosed |
| WO-2010031047-A2 | DETECTION OF VAPOR PHASE COMPOUNDS BY CHANGES IN PHYSICAL PROPERTIES OF A LIQUID CRYSTAL | PLATYPUS TECHNOLOGIES, LLC (US) | 2010-03-18 | — | — | WO | disclosed |
| US-20100055576-A1 | tert-BUTYLPHENYL SULFONATE COMPOUND, NONAQUEOUS ELECTROLYTE SOLUTION FOR LITHIUM SECONDARY BATTERY USING THE SAME, AND LITHIUM SECONDARY BATTERY USING THE SAME | MU IONIC SOLUTIONS CORPORATION (JP) | 2010-03-04 | — | — | US | disclosed |
| CN-101646648-A | Tert-butylphenyl sulfonate compound, nonaqueous electrolyte solution for lithium secondary battery using same, and lithium secondary battery using same | UBE IND JP | 2010-02-10 | — | — | CN | disclosed |
| EP-2133327-A1 | tert-BUTYLPHENYL SULFONATE COMPOUND, NONAQUEOUS ELECTROLYTE SOLUTION FOR LITHIUM SECONDARY BATTERY USING THE SAME, AND LITHIUM SECONDARY BATTERY USING THE SAME | Ube Industries, Ltd. (JP) | 2009-12-16 | — | — | EP | disclosed |
| US-20080269486-A1 | Reconfigurable molecules and molecular switches, sensors, and dyes employing the same | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. | 2008-10-30 | — | — | US | disclosed |
| US-20080269486-A1 | Reconfigurable molecules and molecular switches, sensors, and dyes employing the same | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. | 2008-10-30 | — | — | US | disclosed |
| WO-2000026173-A1 | NOVEL RETINOIDS, METHODS FOR THEIR PRODUCTION AND USE | LIGAND PHARMACEUTICALS INCORPORATED (DE) | 2000-05-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080269486-A1 | Reconfigurable molecules and molecular switches, sensors, and dyes employing the same | RBX1, DDX1, DDX3X | CA1 2048/4885CA2 2384/4885CA9 2604/4885 |
| US-20100055576-A1 | tert-BUTYLPHENYL SULFONATE COMPOUND, NONAQUEOUS ELECTROLYTE SOLUTION FOR LITHIUM SECONDARY BATTERY USING THE SAME, AND LITHIUM SECONDARY BATTERY USING THE SAME | TERT, TST, TES | CA1 3264/4885CA2 2362/4885CA9 1253/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.